4Penney G, Brechin S de,Souza A,et al. The copper intrauterine device as long-term contraception [J]. J Faro Plann Reprod Health Care,2004,30(2):134.
5Imperato F, Perniola G, Mossa B, et al. The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron tatus (prospective study of 8 years) [J]. Minerva Ginecol, 2002,54(3):271-278.
7FrenehR,Cowan F, MansourD, et al.Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy[J]. CoehraneDatabase Syst Rev,2001,(2):CD001776.
9Hurskainen R, Teperi J, Rissanen P, et al. JAMA. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomize trial 5-year follow-up[J]. JAMA, 2004,291(12) : 1456-1463.
10Vercellini P, FRONTINO G, De Giorgi O, et al. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis:apilot study[J]. Feril Steril,2003,80(2):305-309.
3Gopal KM, Adriana RS, Larry WT, et al. Lysophos-phatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. J Lipid Res,2001,42:1 430-7.
4Liu YX, Liu K, Feng Q, et al. Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type I are coordinately expressed during ovulation in the rhesus monkey. Endocrinology, 2004, 145(4) :1 767-75.
5Mora N, Cano E, Morn EM, et al. Influence of pH and oxygen on copper corrosion in stimulated uterine fluid. Biomaterials,2002, 23(3): 667-71
6Gleeson N, Devitt M, Sheppard BL, et al. Endometrial fibrinolytic enzymes in women with normal menstruation and dysfunctional uterine bleeding. Br J Obstet Gynaecol,1993,100(2): 768-71
7el-Sahwi S, Toppozada M, Kamel M, et al, Prostaglandins and cellular reaction in uterine flushing. I. Effect of IUD insertion.Adv Contracept, 1987, 3(4): 291-302.
8Toriyabe M, Omote K, Kawamata T, et al. Contribution of interaction between nitric oxide and cyclooxygenases to the production of prostaglandins in carrageenan-induced inflammation. Anesthesiology, 2004, 101(4): 983-90
9Tamaoki J, Yamawaki I, Tagaya E, et al. Effect of azelastine on platelet_activating factor induced microvascular leakage in rat airways. Am J Physiol, 1999, 276(2Pt1 ):L351-7.
10Peplow PV, Hurst PR. Influence of local release of indomethacin form a silastic device on uterine prostaglandins F2 alpha and E. Prostaglandins Leukot Med, 1982,9:437-444.
